ALK-001 phase 2 treatment of stargardt disease IND 108,353 (09/08/2015)
Ended Project Grant Awarded Last action
- Award ID
- R01FD006316
- Recipient
-
Alkeus Pharmaceuticals Inc. UEI MQZNHQ1FW6M3
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $2,750,000
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Originally
- Funding
-
- $2,250,000.00 Federal
- $500,000.00 Non-federal
- Funding agency
- Office of Medical Products and Tobacco Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $500,000 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $500,000 | $0 | |
| Amendment | $500,000 | $500,000 | |
| Amendment | $0 | $0 | |
| Amendment | $500,000 | $0 | |
| Original award | $250,000 | $0 |
Show all 11
Quick answers
Who received award R01FD006316?
R01FD006316 was awarded to Alkeus Pharmaceuticals Inc. by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on July 1, 2018.
How much is award R01FD006316 worth?
$2,750,000 has been obligated on R01FD006316: $2,250,000 in federal funding and $500,000 in non-federal funding.
Which agency awarded R01FD006316?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded R01FD006316, with funding from Office of Medical Products and Tobacco (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award